Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Connect with us at Collision 2024 Viseven’s Chief Brand and Communications Officer, Yuliya Sotska, and Chief Growth Officer, Yaroslava Upatova, will be attending the Collision conference in Toronto on June 17-20, 2024. Viseven will be there for the third consecutive year, and this year Yuliya Sotska will once again be on stage as presenter and moderator. […]
Let’s connect at the Pharma 4.0: Digitalization and Transformation Conference The Viseven team will attend the Pharma 4.0: Digitalization and Transformation Conference. Anna Malivska, product manager and modular approach expert at Viseven, will be one of the conference presenters covering her topic: From Raw Data to Rich Content: Crafting compelling stories with data-driven approaches At […]
Overcome Channel Constraints in Your Content Strategy Creating, approving, and distributing campaigns is an art form that demands careful planning in various scenarios: Join us at the event, where we’ll share insights to help your content thrive across any channel, free from constraints and optimized for omnichannel success. Meet the Experts and See Real Case […]
Connect with us at 2nd Pharma Omnichannel HCP Engagement Conference The Viseven team will attend the 2nd Pharma Omnichannel HCP Engagement Conference, in Lisbon on May 23-24, 2024. Nataliya Andreychuk, co-founder and CEO of Viseven, will be among the conference speakers presenting her topic: “Exploring the Synergy Between High-Quality Content, Data, and AI in Omnichannel […]
Join Us in Unleashing Innovation at NEXT Pharma Summit 2024 The Viseven team is attending the NEXT Pharma Summit 2024 to exchange experience with the leaders of the pharma’s top companies like Bayer, Merck, Biogen, Teva, and more. The conference will take place on May 14-15 in Dubrovnik. These are busy weeks for our team […]
Let’s unlock innovation at Reuters Pharma 2024 The Viseven team is anticipating over 15 hours of networking with top pharma changemakers. Yes, we are referring to Reuters Pharma EU 2024! Join us to discover how to understand HCP preferences, excel in omnichannel marketing, and elevate customer experience. Nataliya Andreychuk, CEO at Viseven, Iryna Zayachuk, Account Manager, […]
Let’s network at REpharmaUSA Join the event that brings together over 100 speakers dedicated to timely delivering life-saving treatments to patients. Don’t miss out on the opportunity to network with the attendees from Viseven, including Oksana Matviienko, Regional Director, and Leonardo Sanchez, AE Lead, at booth number 302. We are eager to engage in discussions […]
Global pharma companies appear to hold all the cards in emerging markets — stronger R&D pipelines, higher digital maturity, and the resources to execute at scale. Yet drug accessibility rarely comes down to a single decision at corporate HQ. Behind every market entry lies a more complex reality: localization is not simply translation, and most […]
In pharma, broken processes have a long shelf life. Content workflows are no exception — teams notice the inefficiencies, the duplicated effort, the review cycles that drag on for too long, but the perceived risk of changing anything keeps them from acting on it. The result is a kind of institutional inertia: everyone sees the […]
Would you be okay starting a therapy with a 2.5-star rating for a condition where every moment impacts clinical outcomes? Now imagine coming across a negative patient review, or seeing a trusted HCP publicly question its effectiveness or highlight side effects. Even in oncology, where treatment decisions are guided by HCPs, what patients read online […]
